Answers are grounded in this paper and cite their sources.
Glucose variability is a potential independent risk factor of poor clinical outcome among people with diabetes, with adequate measurement technically difficult and cumbersome. For this study, a novel 14-day continuous sensor was used to assess glucose variability among people with type 2 diabetes (T2D). The aim was to characterize glucose profiles for up to 2 weeks in T2D and to survey device utilization in a standard clinical setting and its potential to collect clinically meaningful data.
No takes yet. Share an insight, caveat, or question.
Midyett et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: